Publicly available information shows that the price of the original brand-name drug Sotorasib is generally between $1,300 and $2,500, with the exact price depending on the hospital or pharmacy. Price differences are mainly affected by region, purchase channel, and drug specifications. This drug is a prescription drug and is only applicable to patients with KRASG12C-mutant non-small cell lung cancer. Genetic testing is required to confirm the indication before use, and it must be used strictly according to the doctor's prescription.
Factors Affecting Price:
Drug Type
Original brand-name drugs (such as Lumakras from Amgen) are relatively expensive. Compliant generic drugs in some countries or regions are cheaper. Safety and compliance should be the primary considerations when choosing a drug.
Health Insurance Policy
Some regions have included it in their health insurance reimbursement coverage, significantly reducing patients' out-of-pocket expenses. It is recommended to consult your local health insurance department or the hospital you are treating for confirmation.
Specification Differences
Different dosages (e.g., 120mg × 240 tablets/box) or packaging specifications directly affect the total price. A reasonable choice should be made based on the individual's treatment cycle.
Medication Precautions
Easing Financial Burden
If the financial burden is significant, consider pharmaceutical company clinical trials and charitable drug donation programs. Some eligible patients may receive free or low-cost medication support.
Overall Cost Planning
During treatment, follow-up procedures such as imaging examinations are required. Related costs should be budgeted in advance to avoid subsequent financial strain.
Friendly Reminder
Please purchase Sotorasib through official channels to avoid purchasing counterfeit or substandard drugs, which could result in health and financial losses.
